Drug Design & Development

Permanent URI for this collection

http://dspace.alquds.edu:4000/handle/20.500.12213/4755

Overview

The aim of this group is to investigate issues related to acces to health care services. Issue of human rights in health, financial socio-cultural barriers to care, stiga and health care access, quality of life, health coverage and access.

Our Team

    • Rafik Karaman

    Ph.D

    • Jehad Abbadi

    Ph.D.

    Mohannad Qurei

    Ph.D

    Mustafa Khamis

    Ph.D

    Browse

    Browsing Drug Design & Development by Subject "Antibacterials predrugs"

    Now showing 1 - 1 of 1
    • Thumbnail Image
      Item
      Antibacterial Predrugs-from 1899 till 2015
      (WJPPS,Dr. T Pal, 2015-07-08) Elayyan, Sabrin; Karaman, Donia; Mecca, Gennaro; Scrano, Laura; Bufo, Sabino A.; Karaman, Rafik
      The predrug (prodrug) term involves chemically modified inert compound which upon an administration releases the active parent drug to elicit its pharmacological response within the body. For many years, the predrug strategy has been extensively developed to solve many unwanted drug properties. This approach has several advantages over conventional drug administration and it has the potential to be quite effective method for the treatment of diseases in the future. In this mini-review we describe a number of antibacterial agents‘ predrugs, and the ways by which predrug strategy was exploited to overcome many pharmaceutical and pharmacokinetic problems that the parent active antibacterial drugs suffer from such as, low bioavailability by increasing or decreasing lipophilicity, site selectivity for higher absorption and less toxicity, short duration of action to increase patient compliance, rapid metabolism to increase oral bioavailability and masking bitter sensation which is crucial for geriatric and pediatric patient compliance.